Jamie Christensen - 08 Sep 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP & Chief Scientific Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Sep 2023
Net transactions value
-$85,084
Form type
4
Filing time
12 Sep 2023, 17:41:29 UTC
Previous filing
10 Aug 2023
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $85,084 -2,388 -1.6% $35.63 144,032 08 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.